Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Frontiers in Microbiology|February 26, 2015
Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolatesYannick Charretier, Thilo Köhler, Tiphaine Cecchini, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2016
Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical IsolateDelphine Girlich, Rémy A Bonnin, Pierre Bogaerts, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2018
Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-LactamaseLaura Dabos, Pierre Bogaerts, Remy A Bonnin, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in BelgiumPierre Bogaerts, Thierry Naas, Farid El Garch, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamasesHeinrich Delbrück, Pierre Bogaerts, Michaël B Kupper, et al.
Journal of Clinical Microbiology|August 19, 2016
Rapid Identification of OXA-48 and OXA-163 Subfamilies in Carbapenem-Resistant Gram-Negative Bacilli with a Novel Immunochromatographic Lateral Flow AssayFernando Pasteran, Laurence Denorme, Isabelle Ote, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 21, 2020
Evaluation of the Novodiag CarbaR+, a Novel Integrated Sample to Result Platform for the Multiplex Qualitative Detection of Carbapenem and Colistin Resistance MarkersDelphine Girlich, Pierre Bogaerts, Warda Bouchahrouf, et al.
Scientific Reports|April 28, 2023
Minimal requirements for ISO15189 validation and accreditation of three next generation sequencing procedures for SARS-CoV-2 surveillance in clinical settingCéline Maschietto, Gaëtan Otto, Pauline Rouzé, et al.
Infection Control and Hospital Epidemiology|July 7, 2020
Severe influenza/respiratory syncytial virus infections and hospital antimicrobial stewardship opportunities: impact of a 4-year surveillance including molecular diagnosisMarc Bourgeois, Nathalie Ausselet, Veronique Gerard, et al.
International Journal of Antimicrobial Agents|November 26, 2011
Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitalsYouri Glupczynski, Te-Din Huang, Warda Bouchahrouf, et al.
Pageof 9